Marcela V. Maus, M.D.,Ph.D.
8 clinical trials · Sponsor
◉ Watch Marcela V. Maus, M.D.,Ph.D.
| Record | Firm | Date |
|---|---|---|
| CC-97540 in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis (NCT07388277) | Marcela V. Maus, M.D.,Ph.D. | 2026-07-09 |
| Emapalumab Prevention of CAR-T Cell Associated Toxicities (NCT06550141) | Marcela V. Maus, M.D.,Ph.D. | 2024-09-18 |
| CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma (NCT06026319) | Marcela V. Maus, M.D.,Ph.D. | 2023-10-26 |
| Long-term Follow-up of Subjects Treated With CAR T Cells (NCT05024175) | Marcela V. Maus, M.D.,Ph.D. | 2023-08-07 |
| CARv3-TEAM-E T Cells in Glioblastoma (NCT05660369) | Marcela V. Maus, M.D.,Ph.D. | 2023-03-22 |
| TriPRIL CAR T Cells in Multiple Myeloma (NCT05020444) | Marcela V. Maus, M.D.,Ph.D. | 2021-10-05 |
| A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity (NCT04150913) | Marcela V. Maus, M.D.,Ph.D. | 2020-10-01 |
| CAR-37 T Cells in Hematologic Malignancies (NCT04136275) | Marcela V. Maus, M.D.,Ph.D. | 2020-06-19 |
Track Marcela V. Maus, M.D.,Ph.D. automatically
Every clearance here is in the API, with alerts when new ones post.